NCT01755416 - Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

Type 1 Diabetes

Interventions

DRUG

Closed loop with sensor and Insulin

Subject will be on the closed loop device with enlite sensors for about 27 hours. They will not be on any study medication and will be on insulin alone.

DRUG

Closed loop with sensor, Insulin and Liraglutide

In this study visit the subject will be on the closed loop device with enlite sensors for about 27 hours. In addition to being on insulin, they would take a single injection of 1.2 mg of Liraglutide subcutaneously before dinner on Day 1.

Trial Locations (1)

10467

Albert Einstein College of Medicine West Campus CRC, The Bronx